Use of proteolytic sequences with different cleavage kinetics as a way to generate hydrogels with preprogrammed cell-infiltration patterns imparted over their given 3D spatial structure by Flora, Tatjana et al.
1 
 
Use of proteolytic sequences with different cleavage kinetics as a way to generate 
hydrogels with preprogrammed cell-infiltration patterns imparted over their given 3D 
spatial structure 
 
Tatjana Flora1, I. González de Torre1, 2, M. Alonso1, J. Carlos Rodríguez-Cabello1 
 
1 BIOFORGE, CIBER-BBN, Edificio Lucia, Universidad de Valladolid, Paseo Belén 19, 
47011, Valladolid, Spain 
2 TECHNICAL PROTEINS NANOBIOTECHNOLOGY (TPNBT S.L.) Paseo Belén 9 A, 
47011, Valladolid, Spain 
Tatjana Flora  
G.I.R BIOFORGE, CIBER-BBN, Universidad de Valladolid 
Paseo de Belén 19 
47011, Valladolid, Spain 
E-mail: tflora@bioforge.uva.es 
Dr. Israel Gonzalez de Torre 
TECHNICAL PROTEINS NANOBIOTECHNOLOGY (TPNBT S.L.) 
Paseo Belén 9 A, 
47011, Valladolid, Spain 
E-mail: igonzalez@tpnbt.com 
 
Prof. Matilde Alonso 
G.I.R BIOFORGE, CIBER-BBN, Universidad de Valladolid 
Paseo de Belén 19 
47011, Valladolid, Spain 
E-mail: malonso@bioforge.uva.es 
 
Prof. José Carlos Rodríguez-Cabello 
G.I.R BIOFORGE, CIBER-BBN, Universidad de Valladolid 
Paseo de Belén 19 
47011, Valladolid, Spain 
E-mail: roca@bioforge.uva.es 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
Abstract.  
Control over biodegradation processes is crucial to generate advanced functional structures 
with a more interactive and efficient role for biomedical applications.  
Herein, a simple, high-throughput approach is developed based on a 3D-structured system 
that allows a preprogramed spatial-temporal control over cell infiltration and biodegradation. 
The 3D-structured system is based on elastin-like recombinamers (ELRs) characterized by 
differences in the kinetics of their peptide cleavage and consists of a three-layer hydrogel disk 
comprising an internal layer containing a rapidly degrading component, with the external 
layers containing a slow-degrading ELR. This structure is intended to invert the conventional 
pattern of cell infiltration, which goes from the outside to the inside of the implant, to allow 
an anti-natural process in which infiltration takes place first in the internal layer and later 
progresses to the outer layers. Time-course in vivo studies proved this hypothesis, i.e. that it is 
possible to drive the infiltration of cells over time in a given 3D-structured implant in a 
controlled and predesigned way that is able to overcome the natural tendency of conventional 
cell infiltration. The results obtained herein open up the possibility of applying this concept to 
more complex systems with multiple biological functions.  
 
Keywords: angiogenesis, elastin-like recombinamers, tunable degradation rate, hydrogels, 
biomaterials. 
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1. Introduction 
 
Over the past few years, the application of microfabrication and additive fabrication tools in 
the biomedical field has produced remarkable advances in the generation of complex 
structures with well-defined architectures that mimic those found in natural tissues and organs. 
[1] [2] Currently, the construction of well-defined three-dimensional (3D) structures is one of 
the most widespread strategies used in regenerative medicine. Indeed, this strategy has led to 
the construction of complex structures with controlled geometries and with precise control 
over the composition and spatial distribution. [3, 4] In most cases, these systems are 
conceived as transient, thus meaning that, once implanted, they either progressively degrade 
via a chemical process or are digested by the direct action of their cellular cargo or cells 
recruited from the surrounding tissues. In both cases, the implant is degraded and disappears 
from the implantation site, with natural tissue replacing the degraded implant. [5] [6] 
Fabrication techniques for well-defined 3D structures still face technical challenges in terms 
of high-resolution cell deposition, controlled cell distributions and vascularization. [7] [8] 
Apart from these challenges, one evident drawback of current technology is the lack of 
spatial-temporal control during the degradation process. [8] In general, the well-defined 3D 
structure of these implants is not related to their degradation process, at least in a controlled 
manner. Essentially, after implantation, the cells colonize and degrade the implant in an 
uncontrolled way, thus meaning that the spatial structure and biological function distribution 
of the implant are not connected with a predefined degradation program. [9] It would 
therefore be highly desirable for such sophisticated 3D structures to show a linked and 
programmable degradation sequence as a way of better controlling the evolution of the system 
once implanted. [10] [11] Currently, control of degradation rate over time is crucial for 
scaffolds used in tissue-engineering applications and is a key factor influencing the structure 
and properties of the scaffold. [12] [13] [14] 
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Elastin-like recombinamers (ELRs) are considered to be advanced biomaterials since they are 
multifunctional materials that can be tailored to exhibit a wide range of properties as well as 
functionalities such as cell adhesion, cell signaling, elasticity and biodegradability. [15] [16] 
[17] Moreover, they can be genetically engineered to exhibit complex biological 
functionalities as well as stimuli-responsiveness and, more specifically, they can change their 
physicochemical properties as a result of a change in a given stimulus. [18] [19] These smart 
biomaterials allow for the emulation of key properties of the natural ECM, specifically the 
ability to mimic its dynamic changes and complex functionalities. [20] [21] These properties 
served as a basis and proved essential when choosing the materials to test the hypothesis of 
this work.  
Biomaterial-based implants that include protease recognition moieties in their amino acid 
composition are one of the most successful approaches towards the generation of functional 
devices. [22] [23] Proteolysis is one of the first and most sustained cell activities responsible 
for the structural remodelling and functional plasticity of tissues, which comprise basement 
membrane degradation, cell migration/ECM invasion, and capillary lumen formation. [24, 25] 
[26] During these processes, cells migrate and locally secrete a number of enzymes that 
promote the degradation and remodelling of matrix molecules in their pathway. Matrix 
metalloproteases (MMPs) and plasmin have been identified as particularly important 
proteases for cell migration. [27] [28] [29] In particular, the plasminogen activator-plasmin 
system plays an important role in tissue remodelling and is involved in several pathological 
processes. Two specific activators and their respective inhibitors, namely tissue plasminogen 
activator (tPA) and urokinase plasminogen activator (uPA), are mainly responsible for 
controlling this system. [30] [31] These activators are synthesized by different cell types, such 
as fibroblasts, epithelial cells, endothelial cells, smooth muscle cells, monocytes/macrophages 
and tumor cells. Moreover, uPA is actively expressed under circumstances associated with 
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cell migration (reparation, inflammation, angiogenesis, metastasis), where it provides efficient 
and spatially restricted extracellular proteolysis. [31, 32] [33] 
Recent studies have shown the potential of the creation of 3D microenvironments that behave 
like actual ECM tissue. These 3D microenvironments can incorporate biological cues, such as 
protease epitopes, or growth factors to facilitate ECM degradation, cell proliferation, 
angiogenesis, or regeneration. They can also improve tissue specificity and facilitate 
maintenance of cell functions and phenotype. [34] [35] 
Recently, Straley et al. demonstrated that the kinetics and sensitivity to proteolytic cleavage 
epitopes of uPA are not the same. Thus, whereas some epitopes, such as GTAR, exhibit a 
high sensitivity to proteolytic cleavage with a fast response, others, such as DRIR, exhibit a 
low cleavage efficiency, thus resulting in a delayed proteolytic sensitivity and slower 
degradation kinetics. [36] 
We propose that the differences in peptide cleavage kinetics between those two epitopes can 
be used to program the degradation and cell-invasion sequence in a given 3D structure. To 
test this hypothesis, a model 3D structure (a sandwiched three layer disc) was constructed 
(Figure 1). This was accomplished using ELRs containing both adhesion (RGD sequence) and 
specific proteolytic sites belonging to the plasminogen activator system (uPA enzyme) but 
with different degradation rates (fast and slow). The combination of these two types of 
bioactive signals allowed for the construction of a 3D system with a preprogrammed 
degradation sequence. This 3D model construct consisted of two external layers formed by a 
mixture of a proteolytic ELR with a slow degradation rate (DRIR-ELR) and an RGD-ELR, 
and a central layer composed of a proteolytic ELR with a fast degradation rate (GTAR-ELR) 
in addition to the RGD-ELR (Figure 1a). In essence, these three layers showed the same 
physical properties, cell adhesiveness and other biological functions. The concentration of 
cleavage sites was also the same but the central layer contained the fast degrading GTAR 
sequence while the two external layers contained the slow degrading DRIR sequence.  
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The resulting constructs were implanted subcutaneously in mice in order to analyse cell 
infiltration in a spatial-temporal distribution. (Figure 1b) It is hypothesized that the internal 
layer will be colonized first following an inside-to-outside pattern rather than the outside-to-
inside pattern that is expected in conventional devices without such cell-infiltration 
programming (Figure 1c-1d). 
 
 
Figure 1. Representation of the 3D-structured system with preprogrammed cell invasion. a) A 
sandwiched three layer disc formed by two external layers (white color) characterized by a 
slow degradation rate and a central layer (yellow color) characterized by a fast degradation 
rate. b) This 3D structure was implanted subcutaneously into mice. c) Cells (the black 
structures) invaded the central layer of the system first following an outside-to-inside pattern. 
d) At six weeks post-implantation the central layer of the 3D system had been completely 
degraded, with the consequent formation of functional blood vessels (red circles). The other 
green structures with different shapes represent other kind of cells that invaded the 3D system.  
The last image is an H&E stained image showing that the two external layers of the 3D 
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system with the slow degradation rate were not totally degraded, in contrast to the central 
layer, which was completely degraded.   
 
2. Materials and methods  
2.1 Synthesis of GTAR-ELR and DRIR-ELR 
All gene-synthesis techniques, biosynthesis and purification protocols have been described in 
detail elsewhere. [15] [37] [38] The plasmid pUC57 containing the monomer peptides, GTAR 
and DRIR, was purchased from Nzytech (Lisbon, Portugal). Each monomer was flanked by 
an NheI recognition site. After extraction from pUC57 plasmid, they were inserted into a 
previously linearized and dephosphorylated pDrive vector (Qiagen) containing the 
(((VPGIG)2VPGKG(VPGIG)2)2 block. The multi-block sequence was constructed using a 
directional oligomerization approach called the iterative-recursive method. [39] 
A T4 ligase enzyme was used for ligation. This step was repeated four times in order to 
achieve four repetitions of each gene. Once the genes had been constructed, XL-1 blue 
component cells were transformed. They were then extracted from the pDrive vector and 
subcloned into a p7R expression vector which had previously been cut using SapI and 
dephosphorylated with SAP (Shrink alkaline Phosphatase). Incorporation into the expression 
vector was confirmed by analytical electrophoresis and subsequent DNA sequencing.  
2.2 Expression and characterization of GTAR-ELR and DRIR-ELR  
Expression vectors containing GTAR-ELR and DRIR-ELR genes were transformed into 
BL21 Star (DE3) E.coli strain. A screening of the colonies grown overnight (O/N) in auto-
induction terrific broth (TB) medium was performed. The inoculum with a concentration of 
1.6*109 cells/mL was prepared in Luria-Bertani (LB) medium with ampicillin and glucose 
and incorporated into the fermenter once it had grown. Production in the fermenter allowed 
for the use of a higher culture volume and therefore a higher quantity of the desired ELR to be 
obtained. Bacteria had reached the stationary phase after 15 h, and production was stopped at 
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17 h. However, bacterial lysis ELRs remained in the soluble fraction afterwards. The ELRs 
were purified by inverse transition cycling (ITC), which comprises both hot and cold cycles 
and takes advantage of the smart behaviour of ELRs. The electrophoretic separation of 
proteins corresponding to the different purification steps, and the final product after 
purification, were studied in polyacrylamide gels stained with Coomassie Brilliant Blue.  
In order to ensure the specific features of the final ELR products, physical and chemical 
characterizations were performed. To that end, SDS-PAGE, MALDI-TOF, nuclear magnetic 
resonance spectroscopy (NMR), amino acid analysis (HPLC) and differential scanning 
calorimetry (DSC) techniques were used. (Figure S1-S4, Supporting Information) 
2.3 In vitro analysis of the degradation rate using a recombinant human uPA enzyme 
The degradation rate of GTAR-ELR and DRIR-ELR was studied in vitro using a recombinant 
human uPA enzyme purchased from Hyphen BioMed (Neuville-sur-Oise, France). Each of 
the recombinamers (100 mM) was incubated with the enzyme at a concentration of 580 U/mL 
under sterile conditions. Samples were collected at specific time points (0, 15, 30, 60 minutes 
and 12, 24, 48, 72 hours) and subsequently analysed by SDS-PAGE electrophoresis. For 
analysis, 20 μL of each sample was mixed with 5 μL of loading buffer and heated at 100 °C 
for 10 minutes. The degradation rate was monitored on a 15% SDS-PAGE gel stained with 
Coomassie Brilliant Blue. Each sample was analysed in triplicate.  
2.4 Hydrogel formation and physicochemical characterization 
Hydrogels were obtained by substituting amine groups at the lateral chain of the lysine 
residues of each proteolytic ELR with a cyclooctyne group for subsequent crosslinking by a 
click reaction with RGD-ELR modified with an azide group. Two grams of each proteolytic 
ELR (DRIR-ELR and GTAR-ELR) was dissolved in 40 mL of dimethylformamide (DMF) at 
room temperature (RT) for 1 hour. Afterwards, 133.16 mg of Bicyclo [6.1.0] non-4-yn-9-
ylmethyl N-succinimidyl carbonate (GalChimia, A Coruña, Spain) dissolved in 1 mL of DMF 
was added to the solution and the resulting mixture was stirred for 48 h at RT. RGD-ELR was 
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modified with an azide group as follows. 2-Azido ethyl (2,5-dioxopyrrolidin-1-yl) carbonate 
(51.69 mg) dissolved in 1 mL of DMF was added to the RGD-ELR solution previously 
dissolved in DMF as described above. The modified ELRs were purified by washing with 15 
mL of diethyl ether and the supernatant was removed and washed with acetone (3 x 15 mL), 
dried under reduced pressure, re-dissolved in cold MQ water, dialyzed against MQ water and 
finally lyophilized.  Their modification was studied by MALDI-TOF, NMR, FTIR and DSC 
(Figure S2.1-S2.2, Supporting Information).  
2.5 Porosity studies of proteolytic ELR-based hydrogels 
The porosity of the hydrogels was determined using the following equation:  
Porosity (%) =                  Equation 1 
Where W1 and W2 are the weight of the swollen and lyophilized gels, respectively, dwater is the 
density of pure water and Vhydrogel is the measured volume of the gel in the swollen state. Three 
replicas were measured for each condition.  
2.6 Mechanical properties of proteolytic ELR-based hydrogels 
To prepare the proteolytic ELR-based hydrogels, each proteolytic ELR (GTAR-ELR and 
DRIR-ELR) previously modified with a cyclootyne group was dissolved in PBS 1X at 4°C 
overnight (O/N). The same conditions were used for dissolution of the RGD-ELR previously 
modified with an azide group. The concentrations studied were 50, 100 and 150 mg/mL, with 
a molar ratio of 1:1. For each hydrogel, 50 μL of each proteolytic ELR-cyclootyne was mixed 
in an Eppendorf flask with 50 μL of RGD-ELR-azide. Subsequently, a specific mold was 
used to form the hydrogels, which were incubated at 4°C for 20 minutes. Three replicates 
were analysed for each concentration of each hydrogel.  
The mechanical properties were studied using a strain-controlled AR-2000ex rheometer (TA 
Instruments). A stainless steel with a diameter of 12 mm and a gap of about 1000 between the 
plates was adjusted, reaching a normal force of 0.2 N in order to prevent slippage. All 
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measurements were conducted at 37°C with a frequency sweep of between 0.01 and 50 Hz at 
a fixed strain corresponding to the linear hydrogel region.  
2.7 Morphological characterization by scanning electron microscopy (SEM)  
Hydrogel structure and morphology were evaluated by SEM. After preparation as described 
above, they were dropped into liquid nitrogen, physically fractured, and immersed in liquid 
nitrogen again before finally being freeze-dried. Images of lyophilized hydrogels were 
obtained by SEM (JEOL, JSM-820) with no prior footing procedures. Morphological details 
such as pore size were evaluated quantitatively using the ZEN (Blue Edition, 2012) software 
package (Carl Zeiss Microscopy). 
2.8 In vitro degradation analysis of proteolytic ELR-based hydrogels  
The degradation rate of proteolytic ELR-based hydrogels was studied by evaluating the 
variation of their elastic modulus after incubation with recombinant human uPA enzyme. 
Hydrogels with a concentration of 50 mg/mL previously prepared in a specific mold were 
incubated at 37°C with 1 mL of PBS 0.1 M and uPA enzyme at a concentration of 580 U/mL 
under sterile conditions. Their mechanical properties were analysed using the same approach 
described in section 2.6. 
2.9 Cytocompatibility evaluation in a 2D cell culture 
Human umbilical vein endothelial cells (HUVECs) were obtained from the ATCC (Madrid, 
Spain). Cells were cultured in MED200 medium (Gibco) supplemented with antibiotics 
gentamicin/amphotericin (1%, Gibco) and low serum growth supplement kit (LSGS, Gibco). 
They were maintained in a humidified atmosphere containing 5% CO2 at 37ºC. 
The alamarBlue (Invitrogen) bioassay was used to evaluate the cytotoxicity, determining the 
metabolic activity of HUVECs using a 2D cell culture system consisting of seeding cells on 
top of the hydrogels. At each time point (4 hours, 3 days, and 7 days), the hydrogels were 
washed three times with PBS, then 10% alamarBlue in cell culture medium was added to the 
wells. After each time point, 70 μl of the solutions was transferred into a black, 96-well plate 
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for fluorescence quantification using a microplate reader. A solution of 10% AB in cell 
culture medium and a 100% reduced solution of 10% AB in cell culture medium were used as 
negative and positive control, respectively.   
2.10 In vivo studies of each proteolytic ELR-based hydrogel 
In vivo experiments were performed in accordance with European Union Directive 
2010/63/EU and Spanish Royal Decree RD 53/2013. The protocol was approved by the 
Animal Care and Use Committee of the University of Valladolid. 
Mice were anesthetized by inhalation using 3% Isoflurane, then 30 µL of each hydrogel, with 
a concentration of 50 mg/mL, was injected intramuscularly using a syringe with a 20G needle 
in the hind limb area. Animals were euthanized by cervical dislocation at 3, 6 and 12 weeks.  
2.11 Histology and immunohistochemistry analysis 
The hydrogels were extracted from the animals at the established time point and were 
subsequently embedded in 4% paraformaldehyde at 4°C for at least 24 hours. They were then 
dehydrated in ethanol solutions of increasing concentration (70%, 80%, 90% and 100%); the 
final step comprised two changes in xylene. All samples were fixed in paraffin for at least 5 
hours at 50°C and stored O/N at -20°C. For a general histomorphological evaluation, 
microsections were cut with a rotatory microtome and stained with hematoxylin and eosin 
(H&E) according to standard protocols. [40]  Three randomly chosen areas of histological 
staining were selected to perform quantitative analysis using ImageJ.  
Immunofluorescence staining was performed on micro-sections previously deparaffinised and 
subsequently incubated for 1 hour in 10% donkey blocking serum (Santa Cruz Biotechnology, 
USA). Several washing steps in PBS 1X were then performed. All samples were subsequently 
incubated overnight (O/N) at 4°C with a goat polyclonal primary PECAM antibody (Santa 
Cruz Biotechnology, USA) at a concentration of 1 µg/mL in 1% blocking serum. After the 
primary antibody incubation, samples were washed three times with PBS 1X for five minutes 
each. Each sample was then incubated for 2 hours with donkey anti-goat (Santa Cruz 
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Biotechnology, USA) fluorescein-conjugated secondary antibodies at a concentration of 1 
µg/mL with 1.5% normal blocking serum. Incubation was carried out with minimal light 
exposure. After three washes in PBS 1X for five minutes, a vectashield HardSet Antifade 
Mounting Medium with DAPI (Vector Laboratories, USA) was used to stain the nuclei of the 
cells. All images were acquired using a fluorescent microscope.  
2.12 Preparation of the 3D-structured system 
The 3D system consisted of three layers: two external layers formed by DRIR-ELR and RGD-
ELR and the central layer formed by GTAR-ELR and RGD-ELR. For the preparation of each 
system, a specific mold with a diameter of 0.8 mm and a height of 0.4 mm was used. The first 
step involved depositing the first layer (DRIR-ELR + RGD-ELR) for 2 minutes at 4°C. The 
second layer (GTAR-ELR + RGD-ELR) was then deposited under the same conditions, and 
finally the third layer (DRIR-ELR + RGD-ELR) was deposited. The mold containing the 
entire structure was left for more than 20 minutes at 4°C under sterile conditions.  
2.13 In vivo studies of the 3D-structured system 
The 3D structures were implanted subcutaneously in mice anesthetized using ketamine and 
diazepam at a concentration of 100 and 5 mg/ml, respectively. A small incision was made on 
the dorsal area to form a skin pocket using surgical scissors. The entire cylinder (0.8 mm 
swollen previously in PBS 1X sterile and endotoxin free) was implanted and the wound was 
closed using absorbable sutures. Different time points were analysed (1, 3, 6, 9 and 12 weeks), 
with the animals being euthanized by cervical dislocation at each time point. All samples were 
analysed by histology and immunohistochemistry as described above. Quantitative analysis 
were performed using Image J software as reported above.   
2.14 Statistical analysis  
All data are presented as mean ± SD (n = 3). Statistical analysis involved a one-way analysis 
of variance using the Holm–Sidak method. A p value of less than 0.05 was considered to be 
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statistically significant. (**) p < 0.001, (*) p < 0.05, and p >0.05. n.s.d indicates no significant 
differences. 
3. Results 
3.1 Construction, production and purification of proteolytic ELRs 
The amino acid sequences of the resulting proteolytic ELRs (GTAR and DRIR) are shown in 
Table 1. Each proteolytic ELR comprises a main block (((VPGIG)2VPGKG (VPGIG)2)2, 
which is repeated four times, with each cleavage peptide appearing in the middle. The entire 
DNA sequencing and restriction mapping analysis showed the accuracy of the gene-
construction process. (Figure S1) 
Purification were carried out using an ITC protocol and the production yields obtained were 
around 350 mg/L of bacterial culture. The purity, molecular mass and correctness of the 
biosynthetic process of the final product were confirmed by SDS-PAGE electrophoresis 
(Figure S2), FTIR (Figure S3), MALDI-TOF mass spectrometry (Figure S4), and amino acid 
analysis (Table S1). 
Table 1. Amino acid sequence of the proteolytic ELRs 
Proteolytic ELRs                                                                    Amino acid sequence   
GTAR MESLLPV (((VPGIG)2 VPGKG (VPGIG)2)2YAVTG DRIR SASPASSA ((VPGIG)2 VPGKG (VPGIG)2)2V)4 
DRIR MESLLPV(((VPGIG)2 VPGKG (VPGIG)2)2YAVTG GTAR SASPASSA ((VPGIG)2 VPGKG (VPGIG)2)2V)4 
 
3.2. In vitro enzymatic degradation of proteolytic ELRs 
The degradation rate of each proteolytic ELR (GTAR-ELR and DRIR-ELR) was studied in 
vitro by SDS-PAGE electrophoresis with Coomassie Brilliant Blue staining. A representative 
profile of the degradation rate of proteolytic ELRs within a range of time points is shown in 
Figure 2. At time zero, the molecular weight of the bands corresponding to the recombinamer 
was about 42 kDa. After 15 minutes, the full protein degraded into smaller fragments with 
molecular weights of approximately 35, 25, 15 and 5 kDa. The size of these bands 
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corresponds to the theoretical length of the fragments generated upon cleavage at the 
proteolytic sites. The presence of other fragments that do not correspond to these molecular 
weights is due to the residual nonspecific cleavage of lysine sites. [41] After 60 minutes, a 
clear difference was noted between the recombinamer with a fast degradation rate and the 
recombinamer with a slow degradation rate. Thus, the upper bands of the recombinamer with 
a fast degradation rate (GTAR-ELR) were absent and the smallest band of 5 kDa increased in 
intensity. After 12 hours, GTAR-ELR was completely degraded and the only remaining band 
was that at 5 kDa. The recombinamer with a slow degradation rate did not reach complete 
degradation over the time period studied. One change that can be noticed for these time points 
is the loss of intensity in the upper bands, thus meaning that the band corresponding to the full 
protein began to degrade. These results indicate that there is a clear difference between the 
ELRs with fast and slow degradation rates and that the degradation rate can be modified using 
these different cleavage sites. 
                             
Figure 2. SDS-PAGE electrophoresis of the proteolytic ELRs: a) GTAR-ELR, b) DRIR-ELR. 
15% SDS-PAGE stained with Coomassie. In both gels: Lines 1-4: proteolytic ELR 
15 
 
degradation after 0, 15, 30 and 60 minutes. Line M: Page Ruler unstained Protein Ladder. 
Lines 5-7: protein degradation after 12, 24, and 48 hours.  
3.3 Morphology studies of proteolytic ELR-based hydrogels 
The morphology of the proteolytic ELR-based hydrogels at several concentrations in a frozen-
lyophilized state was analysed by SEM microscopy. SEM micrographs of GTAR-ELR and 
DRIR-ELR hydrogels at several concentrations (50, 100 and 150 mg/mL) can be found in 
Figure 3a and 3b, respectively. It is evident that the dried porosity decreases with increasing 
concentration. In hydrogels with a concentration of 100-150 mg/mL, the shape of the pores is 
irregular and some zones are characterized by a non-pore size. It is also clear that their 
structure converts into a denser and tighter structure formed by smaller pores. The hydrogels 
with a concentration of 150 mg/mL present a collapsed network, thus leading to a shrunken 
state. There is an inverse correlation between concentration and pore size, which further 
affects the swelling ratio. Hydrogels with a concentration of 50 mg/mL display a higher 
number of pores with a regular and ordered porosity and also maintain high interconnectivity. 
A quantitative analysis of the pore size was performed using the ImageJ software, giving a 
range of about 13 µm. The microscopic structure of the proteolytic ELR-based hydrogels was 
studied in more detail in order to determine the porosity values, which are reported 
graphically in Figure 3c. The porosity of the hydrogels was evaluated as a function of 
concentration, demonstrating that porosity decreases with increasing concentration. These 
results are in agreement with the SEM analysis. Moreover, both ELR-based hydrogels 
(GTAR-ELR and DRIR-ELR) exhibit similar morphological features at a concentration of 50 
mg/mL.  
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Figure 3. SEM micrographs of cryo-fractured proteolytic ELR-based hydrogels: a) GTAR-
ELR + RGD-ELR based hydrogels at 50, 100 and 150 mg/mL from left to right; b) DRIR-
ELR + RGD-ELR based hydrogels at 50, 100 and 150 mg/mL. Scale bar for all images: 
200µm. c) Graphical representation of porosity versus concentration. Data are reported as 
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mean ± SD. Statistical analysis involved analysis of variance using the Holm–Sidak method. 
*p<0.05; **p<0.001.  
3.4 Mechanical properties of proteolytic hydrogels 
The mechanical properties of the hydrogels were determined by rheological measurement in 
oscillatory mode. Each hydrogel sample was used for only one test and each test was 
performed in triplicate. All rheological tests were performed at 1% strain as a previous 
measurement to demonstrate that the strain amplitude remained constant at 7-8%. The 
complex elastic modulus reported in Figure 4 represents the average of three tests performed 
at 37°C, together with the corresponding standard deviation.  
As reported above, the complex elastic modulus of the hydrogels increased as a function of 
concentration to 1085±145, 2132±192 and 5253±248 Pa for 50, 100 and 150 mg/mL, 
respectively, at a frequency of 1 Hz. A statistically significant difference was found between 
the complex moduli of the hydrogels belonging to the different concentration groups, whereas 
relatively similar values, with no significant difference in complex modulus, were found for a 
given concentration for different proteolytic ELR-based hydrogels. The morphological 
analysis, mechanical properties and swelling ratios demostrated that hydrogels with a 
concentration of 50 mg/mL exhibit similar properties to that for the scaffold used to 
regenerate soft tissues.[42]  Moreover, the different cleavage site does not appear to affect 
their mechanical and morphological properties. [8, 43] 
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Figure 4. Representation of the complex modulus [G*] for GTAR-ELR + RGD-ELR and 
DRIR-ELR + RGD-ELR hydrogels at different concentrations. Data are reported as mean ± 
SD (n=3). Statistical analysis involved analysis of variance using the Holm–Sidak method. 
*p<0.05; **p<0.001; n.d.s. no significant differences. 
 
3.5 Degradation rate of the proteolytic ELR-based hydrogels evaluated by analysing the 
mechanical properties 
The degradation rate of the hydrogels was assessed by monitoring the variation of the elastic 
modulus for 24, 48, 72 and 168 hours. Rheological measurements were performed in 
oscillatory mode, as described above. The resulting complex modulus was compared to the 
measurements at time 0 in order to determine the variation in their magnitude after incubation 
with the corresponding concentration of uPA enzyme. As can be seen from Figure 5, the 
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complex modulus [G*] at time 0 for the hydrogels with a concentration of 50 mg/mL was 
about 1100 Pa. After 24 hours, the complex modulus of the hydrogels with a fast degradation 
rate (GTAR-ELR + RGD-ELR) had decreased by nearly half, whereas the modulus of the 
hydrogels with a slow degradation rate (DRIR-ELR + RGD-ELR) remained unaffected. This 
behaviour was expected for the hydrogels with a fast degradation rate (GTAR-ELR + RGD-
ELR) since the enzyme had cleaved the majority of the proteolytic sites. However, an 
interesting phenomenon was observed after 48 hours. Thus, the complex modulus of the 
hydrogels with a slow degradation rate (DRIR-ELR + RGD-ELR) decreased significantly 
whereas the modulus for the hydrogels with a fast degradation rate (GTAR-ELR + RGD-
ELR) decreased only slightly. After 72 hours, the complex modulus of the hydrogels with a 
fast degradation rate (GTAR-ELR+ RGD-ELR) was impossible to measure due to their loss 
of integrity. As such, the last two points for the measurements are not shown in the graph 
reported in Figure 5. As regards the hydrogels with a slow degradation rate (DRIR-ELR + 
RGD-ELR), the complex modulus started to slowly decrease, reaching a complex modulus of 
676±62 Pa after 168 hours.  
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Figure 5. Graphical representation of the complex elastic modulus [G*] for the proteolytic 
ELR-based hydrogels after exposure to the uPA recombinant human enzyme at 0, 24, 48, 72 
and 168 hours. It was not possible to measure the elastic modulus of the last two time points 
for hydrogels with a fast degradation rate (GTAR-ELR + RGD-ELR). Data are reported as 
mean ± SD. 
 
3.6 Cytocompatibility 
The cytocompatibility of the hydrogels was evaluated using an alamarBlue bioassay 
considering three time points (4 hours, 3 days and 7 days). A representative graph is provided 
in Figure 6, where the cell number is reported for each hydrogel at each time-point. The 
metabolic activity assay revealed that hydrogels promote adherence and proliferation of 
HUVEC cells.  After 4 hours, the endothelial cells adhered similarly in all the hydrogels, and 
at days 3 and 7 the cell metabolic activity increased, thus demonstrating that these hydrogels 
support cell growth and proliferation and confirming their cytocompatibility.  
                     
Figure 6. Cytocompatibility evaluation (adhesion and proliferation of endothelial cells) of 
proteolytic ELRs-based hydrogels using the alamarBlue assay. Error bars represent mean ± 
SD. 
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3.7 Individual in vivo behaviour of proteolytic ELR-based hydrogels 
In this section, we investigate the in vivo behaviour of proteolytic ELR-based hydrogels in 
order to offering a general overview regarding their degradation rate based on the different 
cell invasion behaviours exhibited by them. Thus, the hydrogels were injected intramuscularly 
into mice using a syringe containing a solution of a specific proteolytic ELR and RGD-ELR 
previously mixed in an eppendorf.  
The proteolytic ELR-based hydrogels integrated within the surrounding host tissue, although 
the tissue response after injection was distinct for the hydrogels with a fast degradation rate 
(GTAR-ELR + RGD-ELR) and those with a slow degradation rate (DRIR-ELR + RGD-
ELR). A hydrogel comprising RGD-ELR and VKV-ELR was used as a control. VKV-ELR is 
a recombinamer that does not contain any proteolytic sites.  
As reported in Figure 7a (the first row), after three weeks post-injection, all hydrogels 
remained at the injection site and start to be invaded by cells. A graphic representation 
reported in Figure 7b show significant differences in cell number/mm2 among the samples 
analysed, especially hydrogels with a fast degradation rate (GTAR-ELR+RGD-ELR) 
contained a higher number of cells compared to the other systems tested. On the other hand, 
the hydrogels with a slow degradation rate (DRIR-ELR+RGD-ELR) presented a higher 
number of cells rather than the control (VKV-ELR+RGD-ELR), which contained regions that 
were not invaded by any cells. In addition, cells migrated more deeply into the hydrogels with 
a fast degradation rate (GTAR-ELR+RGD-ELR) than into those with a slow degradation rate 
(DRIR-ELR+RGD-ELR), almost certainly as a consequence of their degradation rate. We 
hypothesize that the cells colonizing the hydrogels were a heterogeneous population of cells 
characteristic of the acute inflammatory response, which is a peripheral reaction during 
inflammatory infiltration. These results offer an insight into how the different degradation 
rates influence cell migration into the hydrogels, thereby resulting in a marked variation in 
cell density.  
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An interesting event occurred at six weeks post-injection (second row in Figure 7). As regards 
the hydrogels with a fast degradation rate (GTAR-ELR+RGD-ELR), these were found to be 
completely invaded by cells and the formation of small capillaries was observed. In hydrogels 
with a slow degradation rate (DRIR-ELR+RGD-ELR) cells migrated deeper, although some 
areas were not invaded completely. An initial inflammatory response starts which is 
characterized by the presence of macrophages that invaded the hydrogels and started to 
concentrate around the individual hydrogels. (Figure S3.2, Supporting Information) However, 
this inflammatory response was reduced or completely disappeared at the following time 
point. As the degradation process proceeded, a larger number of cells reached deeper within 
the proteolytic hydrogels, thus accelerating their degradation and leading to destruction of 
their structure. (Figure 7c) Moreover, the quantity of cells that invaded the control hydrogel 
was low due to the difficulty encountered by the cells when invading the hydrogel due to the 
lack of proteolytic sites. 
At twelve weeks post-injection signs of degradation became more evident for both proteolytic 
hydrogels, especially their surface area which decreased considerably. At three weeks the area 
of all the hydrogels was about 1.01 mm2. After twelve weeks post-injection the remaining 
area was about 0.89 mm2 for VKV-ELR+RGD-ELR, 0.30 mm2 for GTAR-ELR+RGD-ELR 
and 0.63 mm2 for DRIR-ELR+RGD-ELR. Degradation appeared to be more advanced in 
hydrogels with a fast degradation rate (GTAR-ELR+RGD-ELR), probably indicating 
resorption of the biomaterial. In summary, at six weeks post-injection, the hydrogels started to 
lose their internal structural integrity as the rate of hydrogel degradation was accelerated, thus 
resulting in a noticeably decrease in the volume of the injected hydrogel at twelve weeks post-
injection. 
Additionally, in hydrogels with a slow degradation rate (DRIR-ELR+RGD-ELR) very few 
macrophages were present around the remaining sample whilst in hydrogels with a fast 
degradation rate (GTAR-ELR+RGD-ELR), the inflammatory cells were no longer present. 
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Moreover, in hydrogels with a slow degradation rate vascularization increased compared to 
the previous interval. (Figure S 3.1) Endothelial cells were found to be localized around the 
newly formed capillaries, thus contributing to their luminal structure. (third row of Figure 7a) 
The formation of neo-vascularization was confirmed by immunohistochemical staining using 
an antibody against the PECAM protein. The presence of cells positive for CD31 antigen was 
observed for hydrogels with a fast degradation rate at six weeks post-injection (Figure 8a), 
and for hydrogels with a slow degradation rate at twelve weeks post-injection (Figure 8b).   
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Figure 7. a) Histological hematoxylin and eosin (H&E) staining results for ELR-based 
hydrogels at 3, 6, and 12 weeks post-injection. The top row indicates the type of sample 
analysed and the left column indicates the different time points analysed. T: tissue. H: 
hydrogel. The dotted line represents the interface between tissue (muscle) and hydrogel. Scale 
bar: 200 µm. b) Graphic representation of number of cells/mm2 for the hydrogels at three 
weeks post-injection and c) at six weeks post injection. Each data point represents the mean 
number of cells, and the bar represents the standard deviation. *p<0.05; **p<0.001. 
 
Figure 8. CD31 immunofluorescence staining images of: a) GTAR-ELR+RGD-ELR 
hydrogel at 6 weeks post-injection; b) DRIR-ELR+RGD-ELR hydrogel at 12 weeks post-
injection. DAPI: nucleus staining (blue colour). CD31 protein (green colour). Scale bar: 50 
μm. 
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3.8 In vivo studies of the sandwiched three-layer system  
After the in vivo degradation studies of the individual proteolytic hydrogels, a three-
dimensional system mainly comprising a three-layer disc was constructed. This three-layer 
disc comprised two external layers made of DRIR-ELR+RGD-ELR, characterized by a slow 
degradation rate, and a central layer made of GTAR-ELR+RGD-ELR, characterized by a fast 
degradation rate. These discs were implanted subcutaneously in mice and were explanted after 
1, 3, 6, 9 and 12 weeks to evaluate the time-course of cell infiltration.  
Histological examination upon staining with H&E at each time point is shown in Figure 9. As 
can clearly be seen (Figure 9a - 9a1), the three parts of the 3D structure can be easily 
recognized at one week post-implantation. Cell infiltration has not started yet.  
At three weeks post-implantation, (Figure 9b - 9b1), a considerable part of the 3D structure 
was colonized by cells. As predicted, cell infiltration started in the central part of the 3D 
structure, specifically the layer characterized by a fast degradation rate (GTAR-ELR+RGD-
ELR). Figure 9f shows the quantification of cell number/mm2 that started to invade the central 
layer of the 3D structure and the cells that infiltrate the edges of the two external layers. There 
is a significant difference between the quantities of cells that invade the layers of the 3D 
system.  
At six weeks, the central layer of the 3D system was completely invaded by cells and almost 
completely degraded (Figure 9c – 9c1), and a difference in the degradation rate was clearly 
observed at this time point. Thus, the external layer of the 3D structure was still not degraded, 
and the quantity of the cells that invaded these layers clearly increased even if there are 
significant differences between the quantity of cells that invade the central layer of the 3D 
system and the two external layers. (Figure 9g)  
Moreover, at this time point neovascularization was underway as confirmed in Figure 10 a-b-
c where is reported the whole central layer of the 3D system. The blotted circles indicates the 
presence of blood vessels or capillaries formed. In some of these structures is possible to 
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detect the presence of endothelial cells surrounding the red blood cells, thereby suggesting the 
presence of a functional vasculature. (Figure a1, b1, c1) Immunofluorescent staining analysis 
for a well-known endothelial marker (CD31) was performed. A considerable amount of 
CD31-positive cells were detected in the central layer of the 3D system (Figure 10d) 
demonstrating a highly vascularized structure and confirming the presence of blood vessel 
(Figure 10 d1) that favour the transport of nutrients between the 3D structure and the host 
tissue. It is evident that the two external parts of the 3D system have no vascularization yet.  
At nine weeks post-implantation, the external layers of the 3D structure were almost 
completely degraded (Figure 9d – 9d1). Although some remnants of the hydrogels remained, 
they were completely invaded by cells. 
The final time point was at 12 weeks. The animals were sacrificed at this point, and no 
hydrogels remained in the area where they were implanted. Given our previous findings, this 
allowed us to hypothesize that the entire system had been completely reabsorbed. A summary 
of the degradation process of the 3D structure when implanted subcutaneously, and how the 
size thereof changes with time up to the final time point, is provided in Figure 11. At the first 
three time points the three-layer disc is clearly visible under the skin, thus indicating that it 
had yet no degraded substantially, and there are no, or very few, macroscopic signs of 
inflammation or toxicity in the tissue surrounding the implant. 
 
27 
 
 
 
 
28 
 
 
 
Figure 9. Histological analysis with H&E staining of the 3D structure at: a) 1 week post-
implantation, a2) magnification of image where the three parts of the 3D system can be 
recognized a; b) 3 weeks post-implantation, b1) magnification of image b where it can be 
observed the initial phase of cell invasion; c) 6 weeks post-implantation, c1) magnification of 
image c where it can be noticed the complete degradation of the central part of the 3D system; 
d) 9 weeks post-implantation, d1) magnification of image d where it can be observed the 
complete cellular invasion and almost complete degradation of the two external parts of the 
3D system. The dotted circle indicates the part of the image which was magnified f) graphic 
representation of number of cells/mm2 that invaded the three parts of the 3D system after 
three weeks post-implantation and g) after six weeks post-implantation. Data are reported as 
mean ± SD. *p<0.05; n.s.d no significant differences. 
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Figure 10. Histological analysis with: (a, b, c) H&E staining of the central part of the 3D-
structured system at six weeks post-implantation. a1) magnification of zone a b1) 
magnification of zone b c1) magnification of zone c. Blotted circles indicates the presence of 
blood vessels or capillaries. d) CD31 immunofluorescent stain of the whole 3D system. 
Blotted circle indicates the area magnified in d1) magnification of the central area of the 3D 
system.  Nuclei are stained blue with DAPI and overlaid with green-CD31. Scale bars: a, b, c, 
d) 100 μm; a1, b1, c1, d1) 50 μm. 
30 
 
 
Figure 11. Summary of the 3D structure implantation in mice. The circles indicate the 
location of the 3D structure after: a) 1 week; b) 3 weeks; c) 6 weeks; d) 9 weeks post-
implantation; and e) the complete absence of hydrogels after 12 weeks.   
4. Discussion  
 
Control of the biodegradation rate of biological substitutes remains a significant challenge in 
biomedical applications as a balance between neo-tissue formation and scaffold 
biodegradation must be achieved. [44, 45] Biomaterials with a controlled and predictable 
biodegradation are therefore in high demand for the development of multi-functional scaffolds 
that can simultaneously provide mechanical support, reply to biological signals and resist 
physiological loads during the early stages of implementation. [46-48] 
Protease-mediated degradation of biomaterials currently plays an important role in the 
development of 3D-structured systems employed in tissue engineering as it is able to provide 
a more precise and controlled environment for pre-programmed cell infiltration and 
biodegradation. [1] [49]  
The 3D system presented herein consists of a bioactive 3D-structured ELR-based hydrogel 
that provides an appropriate microenvironment for cell growth and proliferation. In particular, 
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this approach consists of controlling the orientation of cell infiltration over time while also 
controlling its structural transformation, thus meaning that it can be applied as a temporary 
soft tissue support for optimal regeneration processes.  
This goal was achieved by synthesizing two different ELRs bearing proteolytic target sites 
with different degradation rates (fast and slow) belonging to the plasminogen activator system, 
specifically to the uPA enzyme, encoded into their backbone. Furthermore, for the 
construction of a 3D structure-system, an ELR containing a universal cell-adhesion sequence 
(RGD) was employed, thereby resulting in the recruitment of a large number of cells inside 
the hydrogel that can trigger enzymes, thereby inducing proteolysis at the protease-sensitive 
sites.  
With regard to their physicochemical characterization (morphological features, mechanical 
properties and cytocompatibility), these ELR-based hydrogels proved to be effective as 
biological substitutes for future applications in tissue engineering. [50-52] [53] [54] 
The degradation rate of these systems was initially studied in vitro using a human 
recombinant uPA enzyme, with a clear difference in terms of degradation being found.  
Initially, the ELR-based hydrogels containing each proteolytic ELR and RDG-ELR were 
investigated in vivo independently in order to determine how their degradation rates influence 
cell invasion and biodegradation. This study showed that there was a clear difference between 
the hydrogels containing the ELR with a fast degradation rate and the ELR-based hydrogels 
with a slow degradation rate in terms of cell-infiltration events, which is an important 
consideration for their subsequent application in tissue engineering. Tuning the design of 
these complex hydrogels by introducing proteolytic sites into the backbone of the protein has 
therefore been shown to improve adhesion and migration while adversely increasing hydrogel 
biodegradation.  
These initial findings allowed us to develop a 3D-structured ELR-based hydrogel consisting 
of two external layers with an ELR characterized by a slow degradation rate and a central 
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layer containing an ELR with a fast degradation rate to achieve predetermined cell invasion, 
thereby improving on conventional systems in which cells infiltrate in a more random manner. 
Several different approaches have been explored previously to control cell migration in 
hydrogels, including chemotaxis, which uses biochemical stimuli incorporated into the 
hydrogel, or durotaxis, which usies substrate rigidity and variations in the stiffness of 
hydrogels to enable cells to preferentially migrate from one region of a hydrogel to another. 
[55] [56] 
Previous studies have demonstrated that synthetic scaffolds, such as PEG hydrogels 
containing MMP-sensitive peptides, display promising features that can support directed and 
guided cell behaviour and vascularization. Additionally, other synthetic scaffolds containing 
collagenase-sensitive peptide sequences have been used in a variety of tissue-engineering 
studies.[57] [57] [58] [59] However, these peptides exhibited slow cleavage rates and their 
incorporation into scaffolds resulted in slow rates of degradation, thus limiting in vivo cell 
invasion, vascularization and neo-tissue formation.  
The 3D-structured ELR-based hydrogels designed herein were implanted subcutaneously in 
mice and cellular infiltration was found to start from the central layer of the structure, which 
comprises the recombinamer characterized by a fast degradation rate, subsequently migrating 
to the external layers, which are characterized by a slow degradation rate. At six weeks post-
implantation, the entire central layer of the system was completely degraded and blood vessel 
formation had begun, thereby facilitating the transport of nutrients. Similarly, at nine weeks 
post-implantation, the two sections characterized by a slow degradation rate had been 
completely invaded by cells and, as a result, were almost completely degraded. Finally, at 12 
weeks, no signs of the 3D-structured ELR-based hydrogel were found, in other words it had 
been completely reabsorbed. To the best of our knowledge, the ability to control cell 
infiltration in vivo using proteolytically mediated hydrogel degradation has not been reported 
previously. 
33 
 
In light of our results, cell invasion can easily be controlled by modulating the degradation 
rate of biomaterials used in the engineered constructs. Moreover, the presence of proteolytic 
target sites with a different degradation rate may potentially lead to more rapid and enhanced 
infiltration in a 3D system.   
 
5. Conclusion  
Hydrogel degradation rate is a crucial aspect that must be taken into consideration when such 
systems are used for biomedical purposes as their utility for a specific application depends on 
the length of time needed for tissue repair. In this study, we have examined a spatial-temporal 
control of cell infiltration into a 3D-structured ELR-based hydrogel made of two specific 
proteolytic ELRs with different degradation rates. A pre-programmed cell infiltration that 
progressed via an inside-to-outside pattern was observed.  
This study offers an insight into the design of a simple 3D-structured system that can be used 
to promote directed and guided cell migration within engineered tissues and could easily be 
implemented for a specific type of tissue regeneration or even for the regeneration of more 
biologically complex structures such as organoids or organs.  
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